The Influence of Gender on Molecular Signatures of Fibrotic Lung Disease
The Influence of Gender on Molecular Signatures of Fibrotic Lung Disease
批准号:
7690831
负责人:
Tara L Sabo-Attwood
金额:
$7.0万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-19 至 2011-04-30
关键词:
AffectAlzheimer&aposs DiseaseAnimalsAreaAsthmaBindingBioinformaticsBiological AssayBiological MarkersCessation of lifeChronicCustomDevelopmentDiagnosisDiagnosticDiseaseDisease ProgressionEndocrineEndocrine systemEnvironmentEnzymesEpidemiologistEstrogensEvaluationEvolutionExtracellular MatrixFemaleGenderGender RoleGene ExpressionGene Expression ProfileGene TargetingGenesGoalsGonadal Steroid HormonesHamman-Rich syndromeHomeostasisHormonalHormonesHumanImmune systemIncidenceIndividualInflammationInterstitial Lung DiseasesInvestigationLeadLogistic RegressionsLungLung diseasesMeasurementMeasuresMediatingMethodsModelingMolecularMolecular ProfilingMolecular TargetNuclear Hormone ReceptorsOsteoporosisPathogenesisPatientsPatternPlayProcessProductionProstatePulmonary FibrosisReceptor SignalingResearchRoleSamplingSeveritiesSeverity of illnessSex CharacteristicsSex PreselectionSignal PathwayStagingStatistical ModelsSteroidsStructure of parenchyma of lungTestingTherapeuticTimeTissue SampleTissuesTranscriptWomanWorkabstractinganimal datadensitydesigneffective therapyexperiencegene interactionimprovedinterestmalemalignant breast neoplasmmenmodel developmentmortalitynovel strategiesoutcome forecastprognosticpublic health relevancereproductivesexsteroid hormonesteroid metabolismtherapeutic development
中文摘要
描述(由申请人提供):
特发性肺纤维化(IPF)是最常见的间质性肺疾病,是一种预后极差的慢性进行性疾病。目前还没有治愈IPF的方法,治疗方案相对无效。死于IPF的人数继续增加,男性死亡率明显高于女性。来自动物研究的数据还显示,男性更容易患上IPF。这些观察结果推断,性别可能在这种疾病的演变中起着重要作用。尽管进行了大量的研究,但对IPF发病机制的了解甚少,很少有研究探讨激素和激素信号通路在IPF中的作用。这项建议的总体目标是确定基因表达变化与疾病严重程度和性别之间的关系。使用不同严重程度的IPF患者的肺组织(由FVC预测确定),我们将设计一种定制的表达分析方法,以同时测量47个基因靶标的转录图谱,其中40个已知在动物和一些人类研究中显示在疾病发展和/或发病机制中具有重要作用(非性别/纤维化基因),以及7个性别相关基因,这些基因可能影响基因表达图谱与疾病严重程度之间的性别相关性。我们的总体假设是,性别将影响目标子集的基因表达水平,这些子集随着疾病严重程度的不同而不同。我们预计性别会影响与性别相关的基因表达特征,而这些特征与非性别相关的基因表达相关,并进一步影响疾病的严重程度。这一假设将在以下两个具体目标中得到验证:(SA1)测量47个基因(与性别相关和与性别无关/纤维化基因)在不同严重程度的IPF患者肺组织样本中的表达水平。为了实现这一目标,将开发定制的QRT-PCR分析方法,并将为每个肺样本确定这些基因的表达水平。(SA2)建立和评估一个两阶段统计模型,从包括性相关和非性相关的47个基因中选择目标基因,确定非性别相关基因的表达水平是否因IPF的严重程度和性别而异,并进一步确定与性相关的基因是否间接影响非性别相关基因的表达水平。从这项工作中获得的信息将为以下方面提供宝贵的信息:(1)哪些基因,包括性别和非性别相关,在人类患者中都发生了改变;(2)性别的影响是否通过激素受体信号对纤维化基因的调节;(3)激素受体信号对IPF严重程度的影响是由纤维化基因介导的,还是与我们研究的纤维化基因无关。阐明推动IPF关键基因表达的分子和细胞机制将有助于建立新的或改进的早期疾病生物标记物,并加强治疗和预后策略以治疗早期肺部疾病。(摘要结束)
公共卫生相关性:
项目简介:患有间质性肺疾病(如肺纤维化)的患者面临着有限的治疗选择,这些选择相当无效。男性IPF发病率和死亡率的上升表明,激素可能在疾病的发生和发展中发挥作用。阐明可能有助于IPF产生的分子机制将有助于改进患者的诊断和治疗,并建立内分泌系统与肺部疾病之间的关系。
英文摘要
DESCRIPTION (provided by applicant):
Idiopathic pulmonary fibrosis (IPF), the most common form of interstitial lung disease, is a chronic progressive disorder associated with extremely poor prognosis. There is currently no cure for IPF, and treatment options are relatively ineffective. Death from IPF continues to increase, with mortality rates significantly higher in men than women. Data from animal studies also reveal males are more susceptible to IPF. These observations infer that gender likely plays a significant role in the evolution of this disease. Despite research efforts, mechanisms underlying the pathogenesis of IPF are poorly understood and few studies have investigated the role of hormones and hormonal signaling pathways in IPF. The overall goal of this proposal is to determine the relationship between gene expression changes and disease severity and gender. Using lung tissues from patients diagnosed with IPF of varying severity (determined by FVC predicted), we will design a custom expression assay to measure the transcriptional profile of 47 gene targets simultaneously, 40 known to be important in disease development and/or pathogenesis as shown in animal and some human studies (non-sex/fibrotic genes) and 7 sex-related genes that may influence a gender-dependent association between gene expression profiles and severity of disease. Our overall hypothesis is that gender will influence gene expression levels for a subset of targets which vary with disease severity. We expect gender will influence sex-related gene expression signatures which are associated with non sex-related gene expression and further affect disease severity status. This hypothesis will be tested in the following 2 specific aims; (SA1) To measure the expression levels of 47 genes (sex-related and non sex-related/fibrotic genes) in lung tissue samples of patients diagnosed with IPF of various severity. To complete this aim, custom QRT-PCR assays will be developed and expression levels of these genes will be determined for each lung sample. (SA2) To develop and evaluate a two-stage statistical model to select target genes from 47 genes including sex-related and non sex-related, determine whether non-sex related gene expression levels vary by severity of IPF and gender, and further, whether sex-related genes indirectly affect non-sex related gene expression levels. Information gained form this work will provide invaluable information on (1) which genes, both sex and non sex-related, are altered in human patients; (2) Whether the effect of gender is mediated by hormonal receptor signaling on fibrotic genes; (3) Whether the effect of hormonal receptor signaling on IPF severity is mediated by fibrotic genes or is independent of the fibrotic genes that we investigate. Clarification of the molecular and cellular mechanisms that drive expression of critical genes involved in IPF will aid in establishing new or improved early disease biomarkers and enhancing therapeutic and prognostic strategies to treat incipient lung disease. (End of Abstract)
PUBLIC HEALTH RELEVANCE:
Project Narrative: Individuals with interstitial lung disease such as pulmonary fibrosis are faced with limited treatment options that are rather ineffective. The rising incidence and mortality of IPF in males suggests hormones may play a role in disease development and progression. Elucidation of the molecular mechanisms that may contribute to the production of IPF will lead to improved patient diagnostics and therapeutics as well as establishing relationships between the endocrine system and lung disease.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis.
性别和疾病严重程度对特发性肺纤维化个体基因表达谱的影响。
DOI:
--
发表时间:
2014
期刊:
International journal of molecular epidemiology and genetics
影响因子:
--
作者:
[McGee,SeanP, Zhang,Hongmei, Karmaus,Wilfried, Sabo-Attwood,Tara]
通讯作者:
Sabo-Attwood,Tara
"Linearity assessment methods for sex steroid hormones and carrier proteins among men in the National Health and Nutrition Examination Survey (NHANES III)".
“国家健康和营养检查调查 (NHANES III) 中男性性类固醇激素和载体蛋白的线性评估方法”。
DOI:
10.1016/j.steroids.2013.12.006
发表时间:
2014
期刊:
Steroids
影响因子:
2.7
作者:
[Ritchey,Jamie, Zhang,Hongmei, Karmaus,Wilfried, Steck,SusanE, Sabo-Attwood,Tara]
通讯作者:
Sabo-Attwood,Tara
Assessing the Pulmonary Toxicity of Microplastic Fibers Complexed with Azo Dyes
-
批准号:10593414
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2022
-
负责人:Tara L Sabo-Attwood
-
依托单位:
Contribution of Toll-like Receptors in the Pulmonary Response to Nanoparticles an
-
批准号:8661280
-
项目类别:
-
资助金额:$30.74万
-
财政年份:2012
-
负责人:Tara L Sabo-Attwood
-
依托单位:
Contribution of Toll-like Receptors in the Pulmonary Response to Nanoparticles an
-
批准号:8346247
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2012
-
负责人:Tara L Sabo-Attwood
-
依托单位:
Contribution of Toll-like Receptors in the Pulmonary Response to Nanoparticles an
-
批准号:8510722
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2012
-
负责人:Tara L Sabo-Attwood
-
依托单位:
Mechanisms of Asbestos-Induced CIca1 and Mucin in Lung Epithelium
-
批准号:7335661
-
项目类别:
-
资助金额:$10.5万
-
财政年份:2006
-
负责人:Tara L Sabo-Attwood
-
依托单位:
Mechanisms of Asbestos-Induced CIca1 and Mucin in Lung Epithelium
-
批准号:7531048
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2006
-
负责人:Tara L Sabo-Attwood
-
依托单位: